Stephanie Vine

We get more details on the ready-to-use technologies alliance forged between Schott Pharma, Gerresheimer, and Stevanato.

Is Europe losing its competitiveness in pharma? Claus Zieler of Astellas explains how fragmented reimbursement systems and lengthy approval times are hindering access to medicine.

In this interview, Claus Zieler shares his thoughts on innovation, EFPIA, emerging markets, and Astellas’s growth in the pharma industry

From enhancing drug discovery with AI, to innovations in hot-melt extrusion, continuous processing, generics, and more – check out our free eBook.

Researchers demonstrate anticounterfeiting method that uses DNA oligos integrated into pharmaceutical products.

We speak with Jon Thomas, President and CEO of CIRM to get the background on the California Institute and how it is funding stem cell and gene therapy.

What is the Embocaps Fair Trade Capsules Mark, and how can it improve transparency in pharmaceutical supply chains?

Jon Thomas, CEO of CIRM, discusses the evolution of stem cell research and the future of regenerative medicine in this interview.

Jon Thomas shares how CIRM, the California Institute for Regenerative Medicine, funds cutting-edge regenerative medicine projects while prioritizing diversity and inclusion.

Robert F. Kennedy Jr.'s nomination for US health secretary advances after a tense Senate vote. Democrats call out his anti-vaccine views.